TREM2 and chronic kidney disease: In conclusion, our study not only provides valuable mechanistic insights into the role of Trem2 in regulating macrophage‐mediated inflammation and fibrosis in the AKI–CKD transition but also offers a new avenue for TREM2‐overexpressing macrophage‐based cell therapy to treat kidney diseases.